DETECTION AND LOCALIZATION OF P-GLYCOPROTEIN (P-GP) IN THE KIDNEY

被引：0
|
作者：
TOBE, S [1 ]
LIEBERMAN, D [1 ]
GOLDBERG, H [1 ]
SKORECKI, K [1 ]
REITHMEIER, R [1 ]
机构：
[1] UNIV TORONTO,MEMBRANE BIOL GRP,TORONTO M5S 1A1,ONTARIO,CANADA
来源：
KIDNEY INTERNATIONAL | 1990年 / 37卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：234 / 234
页数：1
相关论文
共 50 条
  • [1] IS INHIBITION OF P-GLYCOPROTEIN (P-GP) SUBSTRATE DEPENDENT?
    Louie, Steven W.
    Hsiao, Peng
    Unadkat, Jashvant D.
    DRUG METABOLISM REVIEWS, 2014, 45 : 252 - 253
  • [2] CHOLESTATIC STEROID GLUCURONIDES - INTERACTIONS WITH P-GLYCOPROTEIN (P-GP)
    VORE, M
    GOSLAND, M
    TSUBOI, C
    HOFFMAN, T
    HEPATOLOGY, 1993, 18 (04) : A139 - A139
  • [3] Localization of P-glycoprotein (ABCB1, P-gp) in brain cellular and subcellular compartments
    Bendayan, R
    Ronaldson, PT
    Lee, G
    Gingras, D
    Bendayan, M
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2004, 52 : S58 - S58
  • [4] Effects of P-glycoprotein (P-GP) inhibitors on CYP3A.
    Wandel, C
    Kim, RB
    Kajiji, S
    Guengerich, FP
    Wood, AJJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 206 - 206
  • [5] P-glycoprotein (P-gp) affects the pharmacodynamics and of the atypical antipsychotic amisulpride
    Schmitt, U
    Hiemke, C
    Härtter, S
    PHARMACOPSYCHIATRY, 2003, 36 (05) : 262 - 262
  • [6] P-glycoprotein (P-gp) affects the pharmacodynamics of the atypical antipsychotic amisulpride
    Schmitt, U
    Härtter, S
    Hiemke, C
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S297 - S297
  • [7] RELUGOLIX ORAL BIOAVAILABILITY IS DRIVEN PREDOMINANTLY BY P-GLYCOPROTEIN (P-GP).
    Buckley, D.
    Migoya, E.
    Lee, T.
    Ferreira, J. Arjona
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S43 - S43
  • [8] Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition
    Dewanjee, Saikat
    Dua, Tarun K.
    Bhattacharjee, Niloy
    Das, Anup
    Gangopadhyay, Moumita
    Khanra, Ritu
    Joardar, Swarnalata
    Riaz, Muhammad
    De Feo, Vincenzo
    Zia-Ul-Haq, Muhammad
    MOLECULES, 2017, 22 (06)
  • [9] Intestinal P-glycoprotein (P-gp) Contribution to Talinolol Pharmacokinetics in Human
    Wan, Christine
    Ishida, Kazuya
    Lai, Yurong
    FASEB JOURNAL, 2022, 36
  • [10] P-GLYCOPROTEIN (P-GP) AND DRUG-RESISTANCE - TIME FOR REAPPRAISAL
    KAYE, SB
    BRITISH JOURNAL OF CANCER, 1993, 67 (04) : 641 - 643
12345